Edition:
United Kingdom

Allena Pharmaceuticals Inc (ALNA.OQ)

ALNA.OQ on NASDAQ Stock Exchange Global Select Market

11.60USD
15 Oct 2018
Change (% chg)

$0.66 (+6.03%)
Prev Close
$10.94
Open
$10.92
Day's High
$11.70
Day's Low
$10.64
Volume
6,295
Avg. Vol
29,801
52-wk High
$17.55
52-wk Low
$6.15

Latest Key Developments (Source: Significant Developments)

Allena Pharmaceuticals Reports Q2 Loss Per Share $0.42
Tuesday, 7 Aug 2018 

Aug 7 (Reuters) - Allena Pharmaceuticals Inc ::ALLENA PHARMACEUTICALS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q2 LOSS PER SHARE $0.42.Q2 EARNINGS PER SHARE VIEW $-0.40 -- THOMSON REUTERS I/B/E/S.PLAN TO INITIATE URIROX-2™ IN 2H18.REITERATES GUIDANCE.ALLENA PHARMACEUTICALS - EXPECT CASH, CASH EQUIVALENTS TO BE SUFFICIENT TO FUND OPERATING. EXPENSES , CAPITAL REQUIREMENTS INTO 2020.  Full Article

Allena Pharmaceuticals Inc - First Patients Treated In Phase 2 Basket Study Of ALLN-177
Monday, 23 Jul 2018 

July 23 (Reuters) - Allena Pharmaceuticals Inc ::ALLENA PHARMACEUTICALS INC - FIRST PATIENTS TREATED IN PHASE 2 BASKET STUDY OF ALLN-177.  Full Article

Allena Pharmaceuticals Reports Q1 Loss Per Share $0.38
Tuesday, 8 May 2018 

May 8 (Reuters) - Allena Pharmaceuticals Inc ::ALLENA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q1 LOSS PER SHARE $0.38.Q1 EARNINGS PER SHARE VIEW $-0.43 -- THOMSON REUTERS I/B/E/S.AS OF MARCH 31, 2018, CASH AND CASH EQUIVALENTS WERE $86.4 MILLION, VERSUS $94.5 MILLION AS OF DECEMBER 31, 2017.CONTINUES TO EXPECT EXISTING CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS INTO 2020.  Full Article

Allena Pharma Reports Q3 Loss Per Share $3.49
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Allena Pharmaceuticals Inc ::ALLENA PHARMACEUTICALS REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q3 LOSS PER SHARE $3.49.Q3 EARNINGS PER SHARE VIEW $-0.50 -- THOMSON REUTERS I/B/E/S.  Full Article

HBM BioCapital II reports 7.94 pct passive stake in Allena Pharma
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Allena Pharmaceuticals Inc :HBM BioCapital II LP reports 7.94 percent passive stake in Allena Pharmaceuticals Inc as of November 6, 2017 - SEC filing‍​.  Full Article

Allena Pharmaceuticals shares open 14.3 pct below IPO price in debut
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - :Allena Pharmaceuticals shares open at $12 in debut on the NASDAQ versus IPO price of $14/shr‍​.  Full Article

Allena Pharmaceuticals prices IPO of 5.3 mln shares at $14 per share
Thursday, 2 Nov 2017 

Nov 1 (Reuters) - Allena Pharmaceuticals Inc :Allena pharmaceuticals, Inc. Announces pricing of initial public offering.Says priced its initial public offering of 5.3 million shares of common stock at a public offering price of $14.00 per share​.  Full Article

Allena Pharmaceuticals sees IPO price range of $14-$16/shr
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Allena Pharmaceuticals Inc :Allena pharmaceuticals Inc sees IPO of up to 5.33 million shares‍​ of common stock to be priced between $14 and $16 per share - SEC filing‍​.  Full Article

BRIEF-Allena Pharmaceuticals Reports Q1 Loss Per Share $0.38

* ALLENA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE